(Q39097813)

English

The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.

scientific article published on January 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

0 references

cancer diagnosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Angela Esposito

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Dario Trapani

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

1 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Current Oncology Reports

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

https://scigraph.springernature.com/pub.10.1007/s11912-017-0564-y

0 references

Reduced lung-cancer mortality with low-dose computed tomographic screening

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Intratumor heterogeneity: evolution through space and time

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Cell-free nucleic acids as biomarkers in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Quantification of free circulating DNA as a diagnostic marker in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Equilibrium separation and filtration of particles using differential inertial focusing

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Highly sensitive enumeration of circulating tumor cells in lung cancer patients using a size-based filtration microfluidic chip

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Microcavity array system for size-based enrichment of circulating tumor cells from the blood of patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

A microfluidic chip integrated with a high-density PDMS-based microfiltration membrane for rapid isolation and detection of circulating tumor cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating tumor cell as a diagnostic marker in primary lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

The identification and characterization of breast cancer CTCs competent for brain metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Detection of mutations in EGFR in circulating lung-cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Combined transcriptome and genome analysis of single micrometastatic cells

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11912-017-0564-Y

21 January 2018

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new device for rapid isolation by size and characterization of rare circulating tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The origin and mechanism of circulating DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/28110461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11912-017-0564-Y

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28110461%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39097813&oldid=1966806675"